These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Somatostatin and analogues in the treatment of VIPoma. O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913 [No Abstract] [Full Text] [Related]
5. Regression of metastatic vipoma with somatostatin analogue SMS 201-995. Clements D; Elias E Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733 [No Abstract] [Full Text] [Related]
7. [Management of insulinoma with the somatostatin analog SMS 201-995]. Gilsanz Peral A; Gómez Balaguer M; Costa Talens P Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658 [No Abstract] [Full Text] [Related]
8. The glucagonoma syndrome. Sonksen PH; Bloom SR J R Soc Med; 1990 Feb; 83(2):127. PubMed ID: 1969482 [No Abstract] [Full Text] [Related]
9. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995]. Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419 [No Abstract] [Full Text] [Related]
10. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592 [No Abstract] [Full Text] [Related]
11. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. Curnow RT; Carey RM; Taylor A; Johanson A; Murad F N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308 [No Abstract] [Full Text] [Related]
12. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage? Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590 [No Abstract] [Full Text] [Related]
13. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome. Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and medical management of insulinomas. Fajans SS; Floyd JC Annu Rev Med; 1979; 30():313-29. PubMed ID: 45408 [No Abstract] [Full Text] [Related]
16. Octreotide--a synthetic somatostatin. Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960 [No Abstract] [Full Text] [Related]
17. Somatostatin analogs in the management of gastrointestinal tumors. Lamberts SW Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogue SMS 201-995 long term therapy for vipoma. Juby LD; Burke DA; Axon AT Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of pancreatic insulin-secreting tumors. Apropos of 2 cases observed personally]. Luyckx A; Zahnd G; Lefebvre P Acta Clin Belg; 1969; 24(2):93-108. PubMed ID: 4322921 [No Abstract] [Full Text] [Related]
20. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]